ABG-WTT Global Life Science Capital Partners GP Ltd

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), ABG-WTT Global Life Science Capital Partners GP Ltd reported 2 stock positions worth $26.8 million. Its top holding was Ceribell (CBLL) at 76.2% of the portfolio, followed by Rapid Micro Biosystems Class A (RPID, 23.8%). Compared with Q1 2025, it sold out of 2. The biggest sale was an exit from CG Oncology (CGON).

Most Recent 13F
Q2 2026
Location
CENTRAL, HONG KONG, K3
CIK
0001832108
Portfolio Value
$26.8M (Q2 2025)
SEC Filing
0000950123-25-008425 ↗ filed Aug 14, 2025

Holdings Value

0$10.0M$20.0M$30.0M$40.0M$50.0M Q1 2024: $41.5M Q1 2024 Q2 2024: $30.0M Q2 2024 Q3 2024: $20.1M Q3 2024 Q4 2024: $43.7M Q4 2024 Q1 2025: $38.3M Q1 2025 Q2 2025: $26.8M $26.8M Q2 2025 Q3 2025: $18.7M Q3 2025 Q4 2025: $15.0M Q4 2025 Q1 2026: $12.3M Q1 2026 Q2 2026: $8.6M Q2 2026

Holdings 2 stocks · $26.8M
CBLL Ceribell Inc. 76.17% 1,088,101 $20.4M No change
RPID Rapid Micro Biosystems Inc. Class A 23.83% 1,848,296 $6.4M No change

Portfolio Sells Q1 2025 → Q2 2025
CGON CG Oncology Inc. Sold out 0.00% −31.67
LUNG Pulmonx Corp. Sold out 0.00% −1.06

Portfolio Buys Q1 2025 → Q2 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$8.6MCBLL, RPID
Q1 2026 2$12.3MCBLL, RPID
Q4 2025 2$15.0MCBLL, RPID
Q3 2025 2$18.7MCBLL, RPID
Q2 2025 2$26.8MCBLL, RPID
Q1 2025 4$38.3MCBLL, CGON, RPID, LUNG
Q4 2024 4$43.7MCBLL, CGON, RPID, LUNG
Q3 2024 3$20.1MCGON, RPID, LUNG
Q2 2024 3$30.0MCGON, RPID, LUNG
Q1 2024 3$41.5MCGON, RPID, LUNG